Literature DB >> 26315523

Screening and Early Detection of Gastric Cancer: East Versus West.

Yun-Suhk Suh1, Han-Kwang Yang2.   

Abstract

Low ratio of mortality over incidence of gastric cancer in Asian countries including Korea and Japan could be explained by early detection after screening, different treatment strategy, or genetic disparity between the East and West. Early detection after screening program for gastric cancer and subsequent surgical treatment including appropriate lymph node dissection has been developed successfully in high risk areas such as East Asian countries. Even in countries with a low prevalence of gastric cancer, a specific screening program is recommended for any high-risk population.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastric cancer; Regional disparity; Screening; Treatment

Mesh：

Year:  2015        PMID： 26315523     DOI： 10.1016/j.suc.2015.05.012

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  24 in total

1.  The FENDRR/miR-214-3P/TET2 axis affects cell malignant activity via RASSF1A methylation in gastric cancer.

Authors:  Zhaocai He; Xin Wang; Changhao Huang; Yu Gao; Chen Yang; Pengwei Zeng; Zihua Chen
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

2.  Interleukin-8: A potent promoter of angiogenesis in gastric cancer.

Authors:  Jun Shi; Pin-Kang Wei
Journal:  Oncol Lett       Date:  2015-12-15       Impact factor: 2.967

3.  Comprehensive Analysis of the Canonical and Non-canonical Wnt Signaling Pathways in Gastric Cancer.

Authors:  Le Wang; Hao Wang; Xianglong Duan; Penggao Dai; Jianping Li
Journal:  Dig Dis Sci       Date:  2019-04-17       Impact factor: 3.199

4.  Classifying risk level of gastric cancer: Evaluation of questionnaire-based prediction model.

Authors:  Maomao Cao; He Li; Dianqin Sun; Lin Lei; Jiansong Ren; Jufang Shi; Ni Li; Ji Peng; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2020-10-31       Impact factor: 5.087

5.  Apatinib plus S-1 for previously treated, advanced gastric or gastro-oesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study.

Authors:  Chao Jing; Zhigang Bai; Jun Zhang; Hongpeng Jiang; Xiaobao Yang; Shu Yan; Jie Yin; Jun Cai; Zhongtao Zhang; Wei Deng
Journal:  J Gastrointest Oncol       Date:  2021-10

Review 6.  Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes.

Authors:  Mason D Stillman; Sam S Yoon
Journal:  J Surg Oncol       Date:  2022-04-13       Impact factor: 2.885

7.  Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Authors:  Claudia Allemani; Tomohiro Matsuda; Veronica Di Carlo; Rhea Harewood; Melissa Matz; Maja Nikšić; Audrey Bonaventure; Mikhail Valkov; Christopher J Johnson; Jacques Estève; Olufemi J Ogunbiyi; Gulnar Azevedo E Silva; Wan-Qing Chen; Sultan Eser; Gerda Engholm; Charles A Stiller; Alain Monnereau; Ryan R Woods; Otto Visser; Gek Hsiang Lim; Joanne Aitken; Hannah K Weir; Michel P Coleman
Journal:  Lancet       Date:  2018-01-31       Impact factor: 79.321

8.  NTRK2 is an oncogene and associated with microRNA-22 regulation in human gastric cancer cell lines.

Authors:  Jinhuai Hu; Yong Huang; Yuanhua Wu; Fengjun Liu; Dong Sun; Kexin Wang; Hui Qu
Journal:  Tumour Biol       Date:  2016-09-23

9.  Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China.

Authors:  Jiuda Zhao; Feng Du; Yu Zhang; Jie Kan; Li Dong; Guoshuang Shen; Fangchao Zheng; Hui Chen; Junhui Zhao; Faxiang Ji; Yang Luo; Fei Ma; Ziyi Wang; Binghe Xu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer.

Authors:  Guoqiao Zheng; Kristina Sundquist; Jan Sundquist; Tianhui Chen; Asta Försti; Akseli Hemminki; Kari Hemminki
Journal:  Clin Epidemiol       Date:  2021-07-02       Impact factor: 4.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.